900000000000508004: Great Britain English language reference set (foundation metadata concept)

SNOMED CT Concept\SNOMED CT Model Component\Foundation metadata concept (foundation metadata concept)\Reference set\Language type reference set (foundation metadata concept)\English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept)\GB English

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT model component module (core metadata concept)

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
GB English	Is a	English [International Organization for Standardization 639-1 code en] language reference set (foundation metadata concept)	true	Inferred relationship	Some

Members	acceptabilityId
pT2a: Tumor confluent with or extending into the ciliary body and/or choroid with melanomalytic glaucoma (iris) (uveal melanoma) (finding)	Preferred (foundation metadata concept)
pT2a: Tumor extends to the soft tissues of the oropharnyx and/or nasal cavity without parapharyngeal extension (nasopharynx) (finding)	Preferred (foundation metadata concept)
pT2a: Tumor invades muscularis propria (stomach) (finding)	Preferred (foundation metadata concept)
pT2a: Tumor invades optic nerve up to, but not through, the level of the lamina cribrosa (retinoblastoma) (finding)	Preferred (foundation metadata concept)
pT2a: Tumor invades superficial muscle (inner half) (urinary bladder) (finding)	Preferred (foundation metadata concept)
pT2a: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension, limited to dermis or greater than 2 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) (finding)	Preferred (foundation metadata concept)
pT2a: Tumor more than 5 cm in greatest dimension, superficial tumor (extraosseous primitive neuroectodermal tumor/Ewing's sarcoma) (finding)	Preferred (foundation metadata concept)
pT2a: Tumor more than 5 cm in greatest dimension, superficial tumor (soft tissue) (finding)	Preferred (foundation metadata concept)
pT2a: Tumour 10 mm to 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) without microscopic extraocular extension (ciliary body and choroid) (uveal melanoma)	Preferred (foundation metadata concept)
pT2a: Tumour confluent with or extending into the ciliary body and/or choroid with melanomalytic glaucoma (iris) (uveal melanoma)	Preferred (foundation metadata concept)
pT2a: Tumour extends to the soft tissues of the oropharnyx and/or nasal cavity without parapharyngeal extension (nasopharynx)	Preferred (foundation metadata concept)
pT2a: Tumour invades muscularis propria (stomach)	Preferred (foundation metadata concept)
pT2a: Tumour invades optic nerve up to, but not through, the level of the lamina cribrosa (retinoblastoma)	Preferred (foundation metadata concept)
pT2a: Tumour invades superficial muscle (inner half) (urinary bladder)	Preferred (foundation metadata concept)
pT2a: Tumour more than 2 cm, but not more than 5 cm, in greatest dimension, limited to dermis or greater than 2 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas)	Preferred (foundation metadata concept)
pT2a: Tumour more than 5 cm in greatest dimension, superficial tumour (extraosseous primitive neuroectodermal tumor/Ewing sarcoma)	Acceptable (foundation metadata concept)
pT2a: Tumour more than 5 cm in greatest dimension, superficial tumour (extraosseous primitive neuroectodermal tumour/Ewing's sarcoma)	Preferred (foundation metadata concept)
pT2a: Tumour more than 5 cm in greatest dimension, superficial tumour (soft tissue)	Preferred (foundation metadata concept)
pT2a: Unilateral, one-half of one lobe or less (prostate)	Preferred (foundation metadata concept)
pT2a: Unilateral, one-half of one lobe or less (prostate) (finding)	Preferred (foundation metadata concept)
pT2b	Preferred (foundation metadata concept)
pT2b (IIB): Extension to AND/OR implants on other pelvic tissues. No malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary)	Preferred (foundation metadata concept)
pT2b (IIB): Extension to AND/OR implants on other pelvic tissues. No malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) (finding)	Preferred (foundation metadata concept)
pT2b (IIB): Invasion of the stromal connective tissue of the cervix (TNM category and FIGO stage) (corpus uteri)	Preferred (foundation metadata concept)
pT2b (IIB): Invasion of the stromal connective tissue of the cervix (TNM category and FIGO stage) (corpus uteri) (finding)	Preferred (foundation metadata concept)
pT2b (IIB): Tumor involves one or both fallopian tubes with extension to other pelvic structures (TNM category and FIGO stage) (fallopian tube) (finding)	Preferred (foundation metadata concept)
pT2b (IIB): Tumor with parametrial invasion (TNM category and FIGO stage) (uterine cervix) (finding)	Preferred (foundation metadata concept)
pT2b (IIB): Tumour involves one or both fallopian tubes with extension to other pelvic structures (TNM category and FIGO stage) (fallopian tube)	Preferred (foundation metadata concept)
pT2b (IIB): Tumour with parametrial invasion (TNM category and FIGO stage) (uterine cervix)	Preferred (foundation metadata concept)
pT2b - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2022) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging.	Preferred (foundation metadata concept)
pT2b category	Preferred (foundation metadata concept)
pT2b category (finding)	Preferred (foundation metadata concept)
pT2b: Melanoma 1.01 to 2.0 mm in thickness, with ulceration (melanoma of the skin)	Preferred (foundation metadata concept)
pT2b: Melanoma 1.01 to 2.0 mm in thickness, with ulceration (melanoma of the skin) (finding)	Preferred (foundation metadata concept)
pT2b: Tumor 10 mm to 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) with microscopic extraocular extension (ciliary body and choroid) (uveal melanoma) (finding)	Preferred (foundation metadata concept)
pT2b: Tumor extends to the soft tissues of the oropharnyx and/or nasal cavity with parapharyngeal extension (nasopharynx) (finding)	Preferred (foundation metadata concept)
pT2b: Tumor invades choroid focally (retinoblastoma) (finding)	Preferred (foundation metadata concept)
pT2b: Tumor invades deep muscle (outer half) (urinary bladder) (finding)	Preferred (foundation metadata concept)
pT2b: Tumor invades subserosa (stomach) (finding)	Preferred (foundation metadata concept)
pT2b: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension, limited to dermis and greater than 2 mm in thickness, but not more than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) (finding)	Preferred (foundation metadata concept)
pT2b: Tumor more than 5 cm in greatest dimension, deep tumor (extraosseous primitive neuroectodermal tumor/Ewing's sarcoma) (finding)	Preferred (foundation metadata concept)
pT2b: Tumor more than 5 cm in greatest dimension, deep tumor (soft tissue) (finding)	Preferred (foundation metadata concept)
pT2b: Tumour 10 mm to 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) with microscopic extraocular extension (ciliary body and choroid) (uveal melanoma)	Preferred (foundation metadata concept)
pT2b: Tumour extends to the soft tissues of the oropharnyx and/or nasal cavity with parapharyngeal extension (nasopharynx)	Preferred (foundation metadata concept)
pT2b: Tumour invades choroid focally (retinoblastoma)	Preferred (foundation metadata concept)
pT2b: Tumour invades deep muscle (outer half) (urinary bladder)	Preferred (foundation metadata concept)
pT2b: Tumour invades subserosa (stomach)	Preferred (foundation metadata concept)
pT2b: Tumour more than 2 cm, but not more than 5 cm, in greatest dimension, limited to dermis and greater than 2 mm in thickness, but not more than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas)	Preferred (foundation metadata concept)
pT2b: Tumour more than 5 cm in greatest dimension, deep tumour (extraosseous primitive neuroectodermal tumor/Ewing sarcoma)	Acceptable (foundation metadata concept)
pT2b: Tumour more than 5 cm in greatest dimension, deep tumour (extraosseous primitive neuroectodermal tumour/Ewing's sarcoma)	Preferred (foundation metadata concept)
pT2b: Tumour more than 5 cm in greatest dimension, deep tumour (soft tissue)	Preferred (foundation metadata concept)
pT2b: Unilateral, involving more than one-half of lobe but not both lobes (prostate)	Preferred (foundation metadata concept)
pT2b: Unilateral, involving more than one-half of lobe but not both lobes (prostate) (finding)	Preferred (foundation metadata concept)
pT2c	Preferred (foundation metadata concept)
pT2c (IIC): Pelvic extension AND/OR implants (T2a or T2b/IIA or IIB) with malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary)	Preferred (foundation metadata concept)
pT2c (IIC): Pelvic extension AND/OR implants (T2a or T2b/IIA or IIB) with malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (ovary) (finding)	Preferred (foundation metadata concept)
pT2c (IIC): Tumor involves one or both fallopian tubes with pelvic extension with malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (fallopian tube) (finding)	Preferred (foundation metadata concept)
pT2c (IIC): Tumour involves one or both fallopian tubes with pelvic extension with malignant cells in ascites or peritoneal washings (TNM category and FIGO stage) (fallopian tube)	Preferred (foundation metadata concept)
pT2c - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2022) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging.	Preferred (foundation metadata concept)
pT2c category	Preferred (foundation metadata concept)
pT2c category (finding)	Preferred (foundation metadata concept)
pT2c: Bilateral disease (prostate)	Preferred (foundation metadata concept)
pT2c: Bilateral disease (prostate) (finding)	Preferred (foundation metadata concept)
pT2c: Tumor 10 mm to 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) with macroscopic extraocular extension (ciliary body and choroid) (uveal melanoma) (finding)	Preferred (foundation metadata concept)
pT2c: Tumor invades optic nerve up to, but not through, the level of the lamina cribrosa and invades the choroid focally (retinoblastoma) (finding)	Preferred (foundation metadata concept)
pT2c: Tumor more than 2 cm, but not more than 5 cm, in greatest dimension, invading the subcutis and/or greater than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas) (finding)	Preferred (foundation metadata concept)
pT2c: Tumour 10 mm to 16 mm in greatest basal diameter and between 2.5 and 10 mm in maximum height (thickness) with macroscopic extraocular extension (ciliary body and choroid) (uveal melanoma)	Preferred (foundation metadata concept)
pT2c: Tumour invades optic nerve up to, but not through, the level of the lamina cribrosa and invades the choroid focally (retinoblastoma)	Preferred (foundation metadata concept)
pT2c: Tumour more than 2 cm, but not more than 5 cm, in greatest dimension, invading the subcutis and/or greater than 6 mm in thickness (carcinoma of skin excluding eyelid, vulva, penis, and melanomas)	Preferred (foundation metadata concept)
pT2d	Preferred (foundation metadata concept)
pT2d - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2022) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging.	Preferred (foundation metadata concept)
pT3	Preferred (foundation metadata concept)
pT3 (III): Local and/or regional spread as specified in pT3a, pT3b, pN1, and FIGO IIIA, IIIB, and IIIC (TNM category and FIGO stage) (corpus uteri)	Preferred (foundation metadata concept)
pT3 (III): Local and/or regional spread as specified in pT3a, pT3b, pN1, and FIGO IIIA, IIIB, and IIIC (TNM category and FIGO stage) (corpus uteri) (finding)	Preferred (foundation metadata concept)
pT3 (III): Tumor extends to pelvic wall (TNM category and FIGO stage) (vagina) (finding)	Preferred (foundation metadata concept)
pT3 (III): Tumor extends to pelvic wall and/or involves lower third of vagina and/or causes hydronephrosis or non-functioning kidney (TNM category and FIGO stage) (uterine cervix) (finding)	Preferred (foundation metadata concept)
pT3 (III): Tumor involves one or both fallopian tubes, with peritoneal implants outside the pelvis (TNM category and FIGO stage) (fallopian tube) (finding)	Preferred (foundation metadata concept)
pT3 (III): Tumor of any size with contiguous spread to the lower urethra and/or vagina or anus (TNM category and FIGO stage) (vulva) (finding)	Preferred (foundation metadata concept)
pT3 (III): Tumour extends to pelvic wall (TNM category and FIGO stage) (vagina)	Preferred (foundation metadata concept)
pT3 (III): Tumour extends to pelvic wall and/or involves lower third of vagina and/or causes hydronephrosis or non-functioning kidney (TNM category and FIGO stage) (uterine cervix)	Preferred (foundation metadata concept)
pT3 (III): Tumour involves one or both fallopian tubes, with peritoneal implants outside the pelvis (TNM category and FIGO stage) (fallopian tube)	Preferred (foundation metadata concept)
pT3 (III): Tumour of any size with contiguous spread to the lower urethra and/or vagina or anus (TNM category and FIGO stage) (vulva)	Preferred (foundation metadata concept)
pT3 - Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging System (2022) https://www.facs.org/quality-programs/cancer/ajcc/cancer-staging.	Preferred (foundation metadata concept)
pT3 and/or N1 (III): Tumor involves one or both fallopian tubes, with peritoneal implants outside the pelvis AND/OR regional lymph node metastasis (TNM category and FIGO stage) (fallopian tube) (finding)	Preferred (foundation metadata concept)
pT3 and/or N1 (III): Tumor involves one or both ovaries with microscopically confirmed peritoneal metastasis outside the pelvis (including liver capsule metastasis) and/or regional lymph node metastasis (TNM category and FIGO stage) (ovary) (finding)	Preferred (foundation metadata concept)
pT3 and/or N1 (III): Tumour involves one or both fallopian tubes, with peritoneal implants outside the pelvis AND/OR regional lymph node metastasis (TNM category and FIGO stage) (fallopian tube)	Preferred (foundation metadata concept)
pT3 and/or N1 (III): Tumour involves one or both ovaries with microscopically confirmed peritoneal metastasis outside the pelvis (including liver capsule metastasis) and/or regional lymph node metastasis (TNM category and FIGO stage) (ovary)	Preferred (foundation metadata concept)
pT3 category	Preferred (foundation metadata concept)
pT3 category (finding)	Preferred (foundation metadata concept)
pT3 stage	Acceptable (foundation metadata concept)
pT3: Discontinuous tumors in the primary bone site (bone) (finding)	Preferred (foundation metadata concept)
pT3: Discontinuous tumors in the primary bone site (osseous primitive neuroectodermal tumor/Ewing's sarcoma) (finding)	Preferred (foundation metadata concept)
pT3: Discontinuous tumours in the primary bone site (bone)	Preferred (foundation metadata concept)
pT3: Discontinuous tumours in the primary bone site (osseous primitive neuroectodermal tumour/Ewing sarcoma)	Acceptable (foundation metadata concept)
pT3: Discontinuous tumours in the primary bone site (osseous primitive neuroectodermal tumour/Ewing's sarcoma)	Preferred (foundation metadata concept)
pT3: Extraprostatic extension (prostate)	Preferred (foundation metadata concept)
pT3: Extraprostatic extension (prostate) (finding)	Preferred (foundation metadata concept)
pT3: Melanoma 2.01 to 4.0 mm in thickness, with or without ulceration (melanoma of the skin)	Preferred (foundation metadata concept)
pT3: Melanoma 2.01 to 4.0 mm in thickness, with or without ulceration (melanoma of the skin) (finding)	Preferred (foundation metadata concept)
pT3: Multiple tumors more than 5 cm or tumor involving a major branch of the portal or hepatic vein(s) (liver, including intrahepatic bile ducts) (finding)	Preferred (foundation metadata concept)
pT3: Multiple tumours more than 5 cm or tumour involving a major branch of the portal or hepatic vein(s) (liver, including intrahepatic bile ducts)	Preferred (foundation metadata concept)

Start Previous Page 12883 of 12901 Next End

Reference Sets

Reference set descriptor

GB English

US English

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
900000000001112010	Great Britain English language reference set	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001113017	GB English	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)
900000000001114011	Great Britain English language reference set (foundation metadata concept)	en	Fully specified name	Active	Entire term case sensitive (core metadata concept)	SNOMED CT model component module (core metadata concept)